BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
CAPS Rating:
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
RSS Headlines
Fool UK
Recs
N1H1 Viris Drug